United States:
Congress Clears Bill to Improve Metabolic Syndrome Support Programs
30 October 2017
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
The House of Representatives and Senate have both approved S 920, the National Clinical Care Commission
Act, clearing the measure for the President. The bill would
establish a national clinical care commission to improve
coordination of federal programs that support care for people with
metabolic syndromes and related autoimmune disorders.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...